with in Biological Technology

Schering-Plough Shareholders Approve Merger With Merck

BOSTON, Aug. 7 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) announced the voting results of a special shareholders meeting today regarding the proposed merger with Merck & Co., Inc. More than 99 percent of votes cast voted to approve the merger agreement, wit...

REPEL-CV(TM) Adhesion Barrier Receives Endorsement of Kids With Heart

ISELIN, N.J., Aug. 7 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, announced today that REPEL-CV Bioresorbable Adhesion Barrier has received the endorsement of Kids With ...

ThermoGenesis Announces Expanded Collaboration With Celling Technologies

RANCHO CORDOVA, Calif., Aug. 6 /PRNewswire-FirstCall/ -- ThermoGenesis (Nasdaq: KOOL ), a leading supplier of innovative products for processing and storing adult stem cells, today announced an expanded collaboration with Celling Technologies ("Celling"), a subsidiary of SpineSmith, ...

Sigma-Aldrich Acquires ChemNavigator, Inc., to Provide Researchers With Industry-Leading Chemical Compound Selection and Procurement Services

ST. LOUIS, Aug. 6 /PRNewswire-FirstCall/ -- Sigma-Aldrich(R) (Nasdaq: SIAL ) today announced the acquisition of cheminformatics company, ChemNavigator(R).com, Incorporated, a provider of leading discovery research informatics software tools used for design, selection and procureme...

PharmatrophiX, Initially Funded by the Alzheimer's Drug Discovery Foundation, Announces Exclusive Global Collaboration with Elan

Promise of revolutionary orally-administered drugs to combat Alzheimer's began journey 8 years ago "Finding a needle in a haystack - 4 molecules out of a million" NEW YORK, Aug. 6 /PRNewswire-USNewswire/ -- New therapeutics funded by the Alzheimer's Dr...

ImmunoVaccine Technologies Partners With Scancell to Advance DNA Vaccine Delivery

HALIFAX, NS, Aug. 5 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a Canadian vaccine development company, has signed an agreement with UK-based Scancell Ltd., the operating company of Scancell Holdings Plc (SCLP.PL), which is developing therapeutic cancer and infectious disease vaccines. T...

Zeus Expands International Support With New Hires

ORANGEBURG, S.C., Aug. 4 /PRNewswire/ -- Zeus, Inc., a global leader in material science and high performance polymer extrusions, has expanded its international personnel with the hiring of David Labelle as its new Business Development Manager and Derek Ramsey in the position of European Sale...

Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab

BETHESDA, Md., Aug. 3 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it has received Orphan Drug Designation from the Europ...

AEterna Zentaris Partner, Keryx, Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine (KRX-0401) for the Treatment of Multiple Myeloma

QUEBEC CITY, Aug. 3 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS , TSX: AEZ), ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ), its partner and licensee for perifosi...

Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients

SAN DIEGO, July 30 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) today announced finalization of the protocol for the Company's Phase II trial of ANA598 in combination with pegylated interferon-alpha and ribavirin in hepatitis C patients. Allowance o...

Biopolymers Symposium 2009 Teams with Carbonfund.org to Create a Zero-Carbon Event

2009 Biopolymers Symposium will support energy efficiency, renewable energy and reforestation projects Falmouth, ME (PRWEB) July 30, 2009 -- IntertechPira has teamed up with Carbonfund.org to create a zero-carbon event. Carbonfund.org has calculated the emissions assoc...

Transave Enters Into Cooperative Research Agreement With NIH To Study ARIKACE(TM) In Nontuberculous Mycobacteria

MONMOUTH JUNCTION, N.J., July 30 /PRNewswire/ -- Transave Inc. announced today that it has entered into a cooperative research and development agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to study ...

Video: New Way RA(TM) Talk Show Premieres Online for People Living With Rheumatoid Arthritis (RA)

HORSHAM, Pa., July 29 /PRNewswire/ -- New Way RA (TM), a new online talk show hosted by award-winning journalist and anchor of Inside Edition, Deborah Norville, premieres today at www.NewWayRA.com . To view the Multimedia News Release, go to: http://www.prnewswire.com/...

Elagolix Successful in Six Month Lilac Petal Study; Safety and Efficacy Confirmed in Patients With Endometriosis

SAN DIEGO, July 29 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) today announced new six month safety and efficacy results from its fourth Phase II clinical trial using its proprietary, orally-active non-peptide Gonadotropin-Releasing Hormone (GnRH) receptor an...

Patent Awarded for a New X-ray Imaging Technology with Capability Unrealized with Present Day Radiological Modalities

Now, a newly patented x-ray microscope technology makes it possible to see every wire in a stent, magnified 25 times larger than actual size, as clearly as if it were being viewed through a microscope, while exposing the animal and researcher to significantly less radiation than current FDA dosa...

Breaking barriers with nanoscale lasers

TEMPE, Ariz. We could soon see the potential of laser technology expand dramatically. Ways to make lasers smaller are being discovered through collaborative efforts of researchers at Arizona State University and Technical University of Eindhoven in the Netherlands. The work opens up possibili...

Microban Partners With YogaDirect.com to Launch Yoga Mats With Zinc Antimicrobial Technology

HUNTERSVILLE, N.C., July 28 /PRNewswire/ -- Microban International, Ltd., the global leader in built-in antimicrobial product protection, has partnered with YogaDirect.com, the largest direct importer and manufacturer of yoga equipment in the U.S., to launch the first ever line of yoga...

Nuevolution Announces Worldwide Technology Cross-Licensing Agreement With GSK

COPENHAGEN, Denmark, July 28 /PRNewswire/ -- Nuevolution today announced the execution of a worldwide technology cross-licensing agreement with GlaxoSmithKline. The agreement relates to a number of patented technologies for rapid synthesis and DNA-tagging of hundreds of millions of chem...

Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)

THOUSAND OAKS, Calif. and LONDON, July 27 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN ) and GlaxoSmithKline (GSK) today announced a collaboration in which the companies will share commercialization of Amgen's monoclonal antibody denosumab for postmenopausal osteoporosi...

NASA Extends Bioastronautics Contract With Wyle for Total Value of $976 Million

EL SEGUNDO, Calif., July 27 /PRNewswire/ -- NASA has exercised a $201 million second option on a contract with Wyle to provide continuing support to the Space Life Sciences Directorate at NASA's Johnson Space Center. The option extends the contract to April 30, 2013. The work will be do...

Cardium Regains Listing Compliance with NYSE Amex

SAN DIEGO, July 27 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM ) ("Cardium") reported that it has received a letter from the NYSE Amex informing Cardium that it had now resolved matters relating to the company's exchange listing compliance. (Logo: ht...

PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2

SOUTH PLAINFIELD, N.J., July 27 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the initiation of a Phase 2 clinical trial of PTC299 in adult patients with neurofibromatosis type 2 (NF2), a rare genetic disorder that causes the development of non-malignant brain tumors....

Patton Medical Devices Partners With Unomedical to Develop and Market the i-port Advance(TM) Injection Port for People Taking Multiple Daily Injections

AUSTIN, Texas, July 27 /PRNewswire/ -- Patton Medical Devices, manufacturer of the i-port(R) and a leader of injection port therapy, announced today that they have entered into a partnership agreement with Unomedical, a leading manufacturer of single use medical devices used in th...

SAPHRIS(R) (asenapine) Meets Primary Endpoint in Long-Term Extension Study in Patients With Predominant, Persistent Negative Symptoms of Schizophrenia

KENILWORTH, N.J., July 24 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today announced that its investigational agent SAPHRIS(R) (asenapine) met the primary endpoint over one year of treatment in an extension study in patients with predominant, persisten...

Time Clocks Technology Catches Up With Crooks

Clocking on and off at work isn't like it used to be. Affordable biometric technology means you can't get someone to buddy punch for you, and you're area access is automatically restricted. What's more - the boss can see where you are, from anywhere on the web, at anytime! ...

Sigma-Aldrich (Nasdaq:SIAL) Reports Q2 2009 Diluted EPS of $0.68; YTD Diluted EPS up 1.5% to $1.36. Full Year 2009 Guidance Reaffirmed, With 2009 Diluted EPS Expected to Exceed 2008's $2.65.

ST. LOUIS, July 23 /PRNewswire-FirstCall/ --Sigma-Aldrich Corporation (Nasdaq: SIAL ), a leading Life Science and High Technology company, reported second quarter 2009 diluted EPS of $0.68 compared to $0.70 in the second quarter of 2008. For the six months ended June 30, 2009, reporte...

Sundia Shortens CRO Shipment Delivery Time with Express Customs Clearance in Shanghai

SHANGHAI, July 22 /PRNewswire-Asia/ -- Since the implementation of Express Customs Clearance on a trial basis a month ago for Sundia MediTech Company and 2 other CRO companies in Zhangjiang Hi-Tech Park in Shanghai, the customs clearance time for Sundia's CRO shipments has been shortened from ...

Axial Biotech Enters Partnership with the University of Utah to Utilize the Utah Population Database to Develop Personalized Diagnostic Tests for Spine Disorders

SALT LAKE CITY, July 22 /PRNewswire/ -- Axial Biotech, Inc., a company personalizing spine care through the development of molecular diagnostics, and the University of Utah today announced that they have entered into a collaboration that allows Axial access to the University's rich ...

Prof. Mario Tredici Shared Views on Algae Projects with Algae Business Players at Algae World!

Algae-based energy and biofuels projects now face critical challenge of cutting costs. According to Top Phycologist Dr. Mario Tredici, technological and biological breakthroughs can offer Algae Biofuels innovative solutions. In his presentation at Algae World, Prof. Tredici shared his innovative ...

Looking Older Than You Are May Have Little to Do With Wrinkles

What's the biggest aging factor and how is it addressed? International Sculptra trainer Dr. Rebecca Fitzgerald, known among her medical colleagues as the "Sculptra guru" here in the U.S., presented her findings on Facial Volume Restoration to an internationally represented group of phys...

Irvine Scientific Announced Today a New Distribution Partnership With Prodimed

SANTA ANA, Calif. , July 21 /PRNewswire/ -- Irvine Scientific announced today a new distribution partnership with Prodimed, a company specializing in women's health, located in Neuilly en Thelle, France. Effective immediately, Irvine Scientific will be distributing Prodimed's extensive l...

Double Helix Strengthens its Strategic Pricing and Reimbursement Practice with Hire of Caryn Zieses

NEW YORK, July 20 /PRNewswire/ -- Double Helix Consulting US, a division of London-based Double Helix Development group, today announced the appointment of Caryn Zieses to the position of Senior Consultant. Zieses joins a multidisciplinary team of highly experienced strategic pricing, reimbu...

iSource Networks Partners with inVentiv Health to Develop New Technology Platform for Reaching Healthcare Consumers

NEWPORT, R.I., July 20 /PRNewswire/ -- iSource Networks, a company focused on improving patient-driven self-care, announced today that it will partner with inVentiv Health, the leading provider of commercialization solutions to the healthcare industry, to develop an innovative new techno...

Hygeia Therapeutics Signs an Exclusive License with Yale University for Potent, Safe Topical Anti-Androgens

Hygeia Therapeutics has added to its portfolio of topical hormonal modulators with the acquisition of a series of potent topical anti-androgens. The compounds are expected to be devoid of systemic activity and will be developed for skin and hair disorders associated with increased sensitivity to...

Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing

BALTIMORE, July 16 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, has established a collaboration with Do-C...

ParagonRx Files with FDA REMS Panel Interim Analysis for Opioid Drugs Study

WILMINGTON, Del., July 15 /PRNewswire/ -- ParagonRx, a healthcare consulting leader in risk management and the appropriate use of drugs, has filed its interim analysis of a study that shows how its proprietary approach to risk management can help manufacturers of opioid drugs meet FDA standar...

Thomson Reuters Partners With Sagient Research

PHILADELPHIA and LONDON, July 15 /PRNewswire/ -- Thomson Reuters today announced a partnership agreement with Sagient Research, a leading provider of biopharmaceutical institutional research. Thomson Reuters will incorporate Sagient's assessments, forecasts and approval timelines on cli...

Covance to Sell Its Interactive Voice and Web Response Services and Enter Into a Multi-Year Marketing Agreement with Phase Forward

PRINCETON, N.J., July 15 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) today announced it has signed an agreement to sell its Interactive Voice & Web Response Services (IVRS/IWRS) business to Phase Forward (Nasdaq: PFWD ). In addition, Covance and Phase Forward have agree...

EnVivo Pharmaceuticals Announces Reversal of Cognitive Deficits in Alzheimer's Disease Transgenic Mouse Model With Gamma-Secretase Modulator

VIENNA, July 14 /PRNewswire/ -- EnVivo Pharmaceuticals today announced at the Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD) the reversal of behavioral deficits observed in an Alzheimer's disease transgenic animal model after chronic oral dosing of a propr...

Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease

VIENNA, Austria, July 14 /PRNewswire-FirstCall/ -- Elan Corporation, plc (NYSE: ELN ) and Wyeth (NYSE: WYE ) presented information this week at the Alzheimer Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) from seven posters and one podium presentation ab...